Yuag, Qiana Mae .
HRN: 29-27-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
CEFTAZIDIME 1GM (VIAL)
07/12/2026
07/19/2026
IVTT
160mg
Q12h
MAP, PSNB
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes